Matches in Wikidata for { <http://www.wikidata.org/entity/Q83794757> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q83794757 description "clinical trial" @default.
- Q83794757 description "ensayu clínicu" @default.
- Q83794757 description "klinisch onderzoek" @default.
- Q83794757 description "клінічне випробування" @default.
- Q83794757 name "Phase I Study of Comparing Single Dose JS005 (Recombinant Humanized Monoclonal Antibody Against IL-17A) With Placebo in Tolerability, Safety, Immunogenicity and Pharmacokinetic in Healthy Volunteers" @default.
- Q83794757 name "Phase I Study of Comparing Single Dose JS005 (Recombinant Humanized Monoclonal Antibody Against IL-17A) With Placebo in Tolerability, Safety, Immunogenicity and Pharmacokinetic in Healthy Volunteers" @default.
- Q83794757 type Item @default.
- Q83794757 label "Phase I Study of Comparing Single Dose JS005 (Recombinant Humanized Monoclonal Antibody Against IL-17A) With Placebo in Tolerability, Safety, Immunogenicity and Pharmacokinetic in Healthy Volunteers" @default.
- Q83794757 label "Phase I Study of Comparing Single Dose JS005 (Recombinant Humanized Monoclonal Antibody Against IL-17A) With Placebo in Tolerability, Safety, Immunogenicity and Pharmacokinetic in Healthy Volunteers" @default.
- Q83794757 prefLabel "Phase I Study of Comparing Single Dose JS005 (Recombinant Humanized Monoclonal Antibody Against IL-17A) With Placebo in Tolerability, Safety, Immunogenicity and Pharmacokinetic in Healthy Volunteers" @default.
- Q83794757 prefLabel "Phase I Study of Comparing Single Dose JS005 (Recombinant Humanized Monoclonal Antibody Against IL-17A) With Placebo in Tolerability, Safety, Immunogenicity and Pharmacokinetic in Healthy Volunteers" @default.
- Q83794757 P1132 Q83794757-E1034A1B-FADB-4B5A-9512-4A3F78596EF9 @default.
- Q83794757 P1476 Q83794757-6E282535-B9D8-4B80-9856-9C34FD7E718A @default.
- Q83794757 P2899 Q83794757-9AEB2DA7-1E37-4F05-AE4F-44DB5CE2CD3C @default.
- Q83794757 P3098 Q83794757-38E9545B-AA9B-4B08-8276-8F9D34209872 @default.
- Q83794757 P31 Q83794757-D03DE241-8D74-4EEE-82C4-9CF78A93671D @default.
- Q83794757 P4135 Q83794757-D4F4E0AE-D421-4073-85A2-3BE9E6A0DF6F @default.
- Q83794757 P4844 Q83794757-847BBCC0-3C04-4A71-BFEB-F73506AEC6AE @default.
- Q83794757 P580 Q83794757-F298E156-0EC7-42AA-8741-2A0C8DA7D322 @default.
- Q83794757 P582 Q83794757-B6671A3C-5CC3-4C09-9FD6-DAC5CFC7FB64 @default.
- Q83794757 P6099 Q83794757-BA4EE107-2ECD-4A43-AD97-3C40E1E2C61A @default.
- Q83794757 P8363 Q83794757-DBDD994E-B8C0-4774-B02E-C02E84084C52 @default.
- Q83794757 P1132 "+40" @default.
- Q83794757 P1476 "Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate the Tolerability, Safety, Immunogenicity and Pharmacokinetic Profile of Single Dose of JS005 (Recombinant Humanized Monoclonal Antibody Against IL-17A) Injection in Healthy Volunteers" @default.
- Q83794757 P2899 "+18" @default.
- Q83794757 P3098 "NCT04220073" @default.
- Q83794757 P31 Q30612 @default.
- Q83794757 P4135 "+45" @default.
- Q83794757 P4844 Q50429626 @default.
- Q83794757 P580 "2020-01-05T00:00:00Z" @default.
- Q83794757 P582 "2020-09-21T00:00:00Z" @default.
- Q83794757 P6099 Q5452194 @default.
- Q83794757 P8363 Q78089383 @default.